/**

• MDX blogpost content. */

Control Print Q1 FY27: Steady core, higher scrutiny on Packaging and Track and Trace

Control Print Limited opened FY27 with a largely steady standalone quarter but a weaker consolidated profitability profile. On a standalone basis, Q1 FY27 income from operations came in at Rs 104.6 crore, up 4.2% year on year. EBITDA was Rs 21.1 crore (20.15% margin) and reported PAT was Rs 12.4 crore (11.84% margin).

Consolidated results showed the impact of investments and losses in newer verticals and overseas subsidiaries. Consolidated Q1 FY27 income from operations was Rs 115.6 crore, with EBITDA of Rs 15.3 crore (13.24% margin) and reported PAT of Rs 3.9 crore (3.39% margin).

Management used the call to reinforce a familiar positioning: Coding and Marking remains the bread-and-butter annuity-like business driven by the installed base, while Track and Trace and Packaging are being built as the next growth platforms. The quarter’s discussion, however, also highlighted that the newer businesses are still in a phase where execution and product readiness matter more than rapid scaling.

The base business: installed base strength, but quarter-to-quarter variability

The investor presentation reiterated the company’s long-term value driver of a Printer and Consumable annuity model, backed by a large installed base. The installed base was stated to exceed 23,000 printers, creating recurring revenue from consumables, spares and services over an estimated 7 to 8 year life due to production line integration and switching costs. The company also reported a market share of 18% to 20% among organised players in India.

In the concall, the CFO stated that 574 printers were sold during Q1 FY27. Management also acknowledged the typical seasonality where Q4 tends to be stronger and Q1 relatively slower. In addition, management linked softer consumable demand during the quarter to sluggish trends in pipes and extrusion related businesses, where a meaningful portion of consumables are used.

The company also spoke about pricing actions. Management said supplier cost increases post-COVID have been sticky and that the company has implemented a price increase and a surcharge since the Iran war began, with the intent of restoring margins that had slipped.

Financial snapshot (Q1 FY27)

Track and Trace: regulatory tailwinds, but product validation is still underway

Control Print’s Track and Trace efforts are positioned under the QRiousCodes brand, described as a cloud-based end-to-end traceability platform that moves the company up the value chain from hardware to the data layer. The presentation listed features such as serialization and aggregation, vision systems, ingredient traceability, warehouse and distribution tracking, and patient engagement tools.

On the concall, management provided two concrete datapoints. First, the total addressable market for Track and Trace was stated to be around Rs 500 to 600 crore per year, including both line equipment and software. Second, management said the company’s Track and Trace sales were around Rs 20 crore in the last financial year.

A key theme in the Q&A was the evolving government mandate for QR codes on pharmaceutical products. Management explained that the current mandate is linked to top 300 brands and that a discussion paper has proposed expanding the scope to top 1,000 brands and certain categories such as antimicrobials and psychotropic substances. Management indicated that if the mandate expands meaningfully, the market could become significantly larger, but they also cautioned that it remains in discussion and the industry may lobby against additional regulation.

Importantly, management did not claim that current QR-based authentication solves counterfeiting. When asked directly whether the loophole of QR codes being copied is solved, management said it is not solved and that the company’s unique propositions are intended to address it. The company also described a model where pricing can be structured per QR code along with line equipment and AMC, and that per-code pricing depends on volume buckets.

Packaging (V-Shapes / CP Italy): demand interest acknowledged, execution remains the bottleneck

Packaging is the most debated growth pillar in the call. The investor presentation positioned V-Shapes as a future consumables engine that replicates Control Print’s consumables annuity playbook, rather than a capex-heavy diversification. The offering described includes packaging equipment for single-dose sachets, co-packaging for small volumes and market testing, and supply of raw materials and laminates.

In the concall, management repeatedly framed the issue as execution rather than demand. They described machine performance challenges, particularly when customers change products frequently. Management said that while machines can be stable when running a single product continuously, frequent changeovers require adjustments and trained operators, otherwise wastage rises and reliability suffers. They also highlighted reputation risk from pushing machine sales before stability is achieved.

Management stated that V-Shapes had previously sold over 70 machines in the market and achieved peak sales of over EUR 12.5 million in 2021, but many of those machines are not running because the system was too fiddly. This context was used to justify the current focus on improving machine performance and internal co-packaging execution.

On timelines, management gave a clear update to an investor question: packaging business break-even is expected in the first half of the next financial year, not in the second half of this year, with a further update expected in Q2.

The presentation also disclosed a related corporate development: on 8 May 2026, the company entered into an IP assignment agreement with CP Italy S.R.L. to acquire intellectual property rights including patents for INR 3,120.11 lakhs. As of 30 June 2026, the full amount was recorded as intangible assets under development.

Capex and manufacturing expansion: Assam project described, incentives uncertain

The investor presentation outlined a new manufacturing facility at Assam intended for extrusion, coding and marking products, and food co-packaging units. The disclosed land area is 46,823 sqm (about 11.57 acres) on a 60-year renewable lease, with total consideration of INR 861.18 lakhs. It was described as eligible under the UNNATI 2024 scheme and strategically important due to synergies with the existing Guwahati facility, with a stated focus on packaging materials.

In the concall, management added an important qualifier: incentives under the scheme were said to be suspended, and the project is awaiting government updates, even though equipment for plastic film manufacturing had been ordered.

What investors can take away from Q1 FY27

The quarter reinforced that Control Print’s near-term predictability still comes from the standalone Coding and Marking business, supported by a large installed base and recurring consumables. Management expressed confidence in maintaining steady growth in this core segment over the year, while working to regain a couple of percentage points in margins through pricing actions.

At the same time, the call made it clear why consolidated profitability remains under pressure. Packaging, in particular, is being managed as a stabilisation and quality-first exercise, with management unwilling to push sales if product performance is not consistently reliable. Track and Trace has a visible regulatory narrative and an existing revenue base, but the more differentiated solutions are still being validated through pilots.

The key monitorables from here are straightforward: whether packaging execution improvements translate into narrowing losses and a credible path to break-even, and whether Track and Trace pilots convert into scalable deployments as regulatory clarity improves. Meanwhile, the core business is expected by management to remain steady, which is critical because it funds the optionality in the newer verticals.